LRRK2 and Parkinson disease: This is further illustrated by the fact that 42 and 12% of the proteins with differential abundance in PD patients vs. controls, as well as 35 and 14% of the proteins that exhibit different abundance in a LRRK2 mutational status‐dependent manner also significantly differed between the sexes in the Columbia and LCC cohorts, respectively.